Scarica l'app Stockscreener
1,064.74
0.02%
-0.26
Pre-mercato:
1067.35
2.61
+0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Barclays Raises Target on Eli Lilly (LLY) After Strong Tirzepatide Growth - Insider Monkey
Trump declares perfect health after Walter Reed physical; Eli Lilly spends $4B on three vaccine developers; obesity leveling off in wealthy nations, still rising elsewhere – Morning Medical Update - Medical Economics
Eli Lilly acquires Novo Holdings-backed Limmatech for USD 780m - medwatch.com
Micron Was Worth Less Than $70 Billion Last Year—Now It's A $1 Trillion Company, Overtaking JPMorgan, Walmart And Eli Lilly - Yahoo Finance
Key facts: Lilly buys 3 vax for up to $4B; PCSK9↓88% LDL‑C↓62%; BofA up GLP‑1 - TradingView
Lilly Follows Upbeat Trials for Cholesterol Shot with $4B M&A Spree - The Daily Upside
GC Biopharma Sells U.S. Affiliate Curevo to Eli Lilly for 459.9 Billion Won - Businesskorea
Eli Lilly Set to Acquire Curevo, LimmaTech Biologics, and Vaccine Co. for $4 Billion - scanx.trade
Lilly buys three vaccine firms to target dementia and infection preventionCHOSUNBIZ - Chosunbiz
Micron Just Became America's 10th-Most-Valuable Company. Wall Street Says It Could Pass Tesla and Meta Next. - The Motley Fool
How The Eli Lilly (LLY) Narrative Is Evolving With GLP-1 Hopes And Obesity Market Doubts - Yahoo Finance
Eli Lilly Buys 3 Vaccine Companies for $3.8B - Powder & Bulk Solids
GC Green Cross Sells U.S. Affiliate Curevo to Eli Lilly - 아시아경제
Former Metro councilman and pastor accused in 'fraud scheme' to steal $200 million from drug company - News Channel 5 Nashville
Lilly spending nearly $4B to acquire three vaccine developers - Inside INdiana Business
Lilly Is Looking for Its Next Act Beyond the Weight-Loss Boom - Barron's
Lilly to acquire three vaccine developers for up to $3.83 billion By Investing.com - Investing.com Canada
Eli Lilly and Company to acquire 3 vaccine development companies for nearly $4 billion - WTHR
Eli Lilly Expands Vaccine Push With Deals Worth Up To $3.8B - Law360
Eli Lilly acquires three vaccine companies for infectious disease portfolio - Managed Healthcare Executive
Lilly goes on $20 billion buying spree as company seeks next act - The Daily Gazette
What's Going On With Eli Lilly Stock Tuesday?Eli Lilly (NYSE:LLY) - Benzinga
Lilly to buy three vaccine developers for up to $3.8 billion - MSN
Lilly to Buy Three Vaccine Developers for Up to $3.8 Billion - marketscreener.com
Lilly Goes on $20 Billion Buying Spree as Company Seeks Next Act - Yahoo Finance
Lilly Gets Back Into the Vaccine Business With New Deals - marketscreener.com
LLY: Eli Lilly Acquires Three Vaccine Developers for $3.8 Billio - GuruFocus
Eli Lilly targets vaccines market with $3.8B acquisition of three biotech firms - Proactive financial news
Lilly buys three vaccine makers; PCSK9 base editor shows promise - BioWorld News
Early data for heart drug affirm Lilly’s billion-dollar bet on Verve - BioPharma Dive
Lilly dives into vaccine research with 3 biotech buyouts - BioPharma Dive
Eli Lilly spending $3.8 billion to buy vaccine makers - Axios
Healthcare Takeovers Tick Pass $140 Billion After Latest Lilly Spree - Bloomberg.com
Lilly goes on $21B buying spree to build drug pipeline - dailyjournal.net
Lilly to buy three vaccine developers for nearly US$4 billion in infectious disease push - CTV News
Eli Lilly and Co. splashes out $3.8 billion to acquire three companies, aiming to get a head start in the next round of the global vaccine race - 富途牛牛
Eli Lilly announces acquisition of 3 vaccine makers in $4 billion deal - upi.com
Analyst recommendations: Eli Lilly, AutoZone, BP plc, Ferrari, Samsung Electronics… - marketscreener.com
Positive Clinical Data for Eli Lilly's Gene Editing Therapy VERVE-102 - GuruFocus
Eli Lilly Bets Nearly $4 Billion on Vaccines: Is the Weight-Loss Drug Giant’s Next Growth Curve Here? - TradingKey
Lilly Expands Into Vaccines With Three Infectious Disease Acquisitions Worth Up to $3.8 Billion - citybiz
Lilly to Acquire Vaccine Company in $1.55 Billion Bet on Epstein-Barr Vaccine Development - citybiz
Lilly to Acquire Curevo in Deal Focused on Next-Generation Shingles Vaccine - citybiz
Eli Lilly to buy trio of vaccine developers in $3.8bn outlay - Pharmaceutical Technology
Eli Lilly and Co (LLY) Stock Price, Trades & News - GuruFocus
Lilly Agrees to Buy Trio of Vaccine Developers - WSJ
Here’s What the Street is Saying About Eli Lilly and Company (LLY) - Insider Monkey
Eli Lilly (LLY) Acquires Three Vaccine Firms for Nearly $4 Billi - GuruFocus
Eli Lilly's VERVE-102 Shows Promising Results in Early Trial - GuruFocus
Eli Lilly (LLY) Expands Vaccine Portfolio with $4B in Acquisitio - GuruFocus
Eli Lilly (LLY) Expands Infectious Disease R&D Through New Acqui - GuruFocus
Lilly (LLY) to Acquire LimmaTech Biologics for Up to $780 Millio - GuruFocus
Eli Lilly to acquire Curevo, LimmaTech Biologics and Vaccine Company in multibillion dollar bet on infectious - CNBC TV18
LLY Acquires Vaccine Company Focused on Innovative Nanoparticle Technology - GuruFocus
LLY Expands Vaccine Portfolio with Curevo Acquisition - GuruFocus
Lilly to buy three vaccine developers for up to US$3.8 bil - The Edge Malaysia
Eli Lilly Doubles Down On Vaccines Portfolio; Makes Three Key Acquisitions For Nearly $4 Billion - NDTV Profit
Is LLY Overvalued? DCF Says Worth $762 - GuruFocus
Lilly acquiring three vaccine developers for nearly $4-billion - The Globe and Mail
Lilly announces three acquisitions to build infectious disease portfolio | Eli Lilly and Company - investor.lilly.com
Eli Lilly (LLY) Expands Portfolio with Infectious Disease Acquis - GuruFocus
Lilly to acquire three vaccine developers for up to $3.83 billion - Investing.com
BofA raises Eli Lilly stock price target on GLP-1 growth outlook - Investing.com
Lilly to acquire three vaccine developers for nearly $4 billion - Reuters
1.78%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):